CDC panel recommends new COVID vaccine boosters

A panel of U.S. health advisers voted to recommend both Pfizer and Moderna's updated COVID-19 boosters that target the newest omicron strains for people 12 and older.

The Centers for Disease Control and Prevention is expected to adopt the recommendation, the last step before shots can begin.

The U.S. still is experiencing tens of thousands of coronavirus cases and about 500 deaths every day, and those numbers are expected to surge again in the fall. Pfizer's option is for people 12 and older while Moderna's is for adults only.